GLP-1 agonists like Wegovy and Zepbound can lead to significant weight loss
a single dose (2) Kainic acid-treated animals may die during an acute period of intoxication, it's suggested to increase the number of animals per group
And by 2023, poison centers logged more than 8,000 GLP-1-related calls.When researchers examined the increase by specific medication, semaglutide accounted for 64% of all GLP-1-related calls, according to the results.One researcher called its dominance "staggering," though she noted that the finding aligns with the drug's extensive media attention.Most of the cases resulted from unintentional dosing or therapeutic errors rather than deliberate misuse.Two of the most common mistakes were patients injecting semaglutide daily instead of weekly and patients starting at the full dose immediately rather than gradually increasing treatment as recommended.The majority of cases involved mild gastrointestinal symptoms
What alternatives exist that dont carry these risks
Collectively, our results demonstrate how the small molecular metabolite C10:2 modulates cellular signaling to drive the pathological progression of PH
Cysteine availability is the limiting factor of GSH synthesis due to the fact that GCLc Km for cysteine, around 270 M, is roughly equal to its intracellular concentration